Health & Medical · Week of Oct 26, 2026
Abbott's MRD test and new Florida vein clinics: the week in health
Abbott launched a cancer MRD test, UVVC opened two Florida vein clinics, and Dario expanded an employer contract, alongside corporate and market-report notices.
No single trend ran through this week's releases. The biggest product news came from Abbott, which launched a next-generation Oncodetect molecular residual disease test built on whole-genome sequencing. In care delivery, United Vein & Vascular Centers opened two Florida clinics on Oct. 26, 2026, in Brandon and Vero Beach. DarioHealth Corp. said a regional grocery retailer extended its contract to add a women's health program.
Corporate and investor notices made up the rest. 111, Inc. said its special committee appointed an independent financial advisor and legal counsel, and Boston Scientific said it will present at Stifel's 2026 Healthcare Conference on November 11, 2026. Research firms DelveInsight and MarketsandMarkets issued market forecasts for JAK inhibitors and patient registry software.

Abbott
Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment
Abbott launched a next-generation Oncodetect MRD test using whole-genome sequencing and MAESTRO technology to detect traces of cancer during and after treatment. The company says it tracks up to 5,000 patient-specific variants, with a limit of detection below one part per million under high-end inputs.

DarioHealth Corp.
Dario Expands Contract with a Leading Regional Grocery Retailer, Adding Women's Digital Health and Clinical Care Program
DarioHealth Corp. says a regional grocery retailer extended its contract to add Dario's women's digital health and clinical care program, following results from Dario's cardiometabolic program and employee demand for perimenopause support. Dario says nearly 45% of its current book of business is women over age 40 who could potentially benefit from Dario Women.
111, Inc.
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
111, Inc. (NASDAQ: YI), a China-based healthcare platform company, announced on Oct. 26, 2026 that its special committee of three independent directors has appointed an independent financial advisor and legal counsel. The appointments are a step in the committee's work, which investors in the company will want to track.

Boston Scientific Corporation
Boston Scientific to participate in Stifel's 2026 Healthcare Conference
Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on Wednesday, November 11, 2026. The company says Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lance Bates, executive vice president, will take part.

DelveInsight Business Research, LLP
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
DelveInsight expects the JAK inhibitors market to grow steadily over its 2026-2036 forecast period. The firm points to the rising prevalence of autoimmune and inflammatory diseases, wider adoption of targeted therapies and expanding clinical use of JAK inhibitors across multiple indications.

MarketsandMarkets
Patient Registry Software Market worth $3.99 billion by 2031 - Exclusive Report by MarketsandMarkets™
MarketsandMarkets projects the patient registry software market will reach USD 3.99 billion by 2031, up from USD 2.47 billion in 2026. That is a CAGR of 10.0% over the forecast period.
United Vein & Vascular Centers
United Vein & Vascular Centers Opens Brandon Vein Clinic, Expanding Access Across Eastern Hillsborough County
United Vein & Vascular Centers opened a vein clinic at 517 Eichenfeld Dr., Suite 106, Brandon, FL 33511, and began seeing patients on Oct. 26, 2026. The company says the clinic offers vein screenings and diagnostic evaluations, expanding access across Eastern Hillsborough County.
United Vein & Vascular Centers
United Vein & Vascular Centers Brings Specialized Vein Care to Vero Beach's Medical District
United Vein & Vascular Centers also opened a vein clinic at 3755 7th Terrace, Suite 202, Vero Beach, FL 32960, which began seeing patients on Oct. 26, 2026. It is the company's second Florida opening announced the same day and offers vein screenings and diagnostic evaluations.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Major Health News reporting.